Echo Therapeutics is developing its non-invasive (transdermal & without needles), wireless, continuous glucose monitoring (CGM) system. A significant opportunity exists for the Company’s CGM to be used in the diabetes fitness, weight loss and personal lifestyle wearable-health space. Echo developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, and enhanced delivery of topical pharmaceuticals.
|HQ||Woodbridge Township, US||Map|
Net income (Q3, 2016)
EBIT (Q3, 2016)
Market capitalization (5-Oct-2018)
|USD||Q3, 2013||Q1, 2014||Q2, 2014||Q3, 2014||Q2, 2015||Q3, 2015||Q3, 2016|
Depreciation and Amortization
Cash From Operating Activities
When was Echo Therapeutics founded?
Echo Therapeutics was founded in 1989.
How many employees does Echo Therapeutics have?
Echo Therapeutics has 19 employees.
Who are Echo Therapeutics competitors?
Competitors of Echo Therapeutics include POPS! Diabetes Care, Insulet and Neurometrix.
Where is Echo Therapeutics headquarters?
Echo Therapeutics headquarters is located at 99 S Wood Ave #302, Iselin, Woodbridge Township.
Where are Echo Therapeutics offices?
Echo Therapeutics has an office in Woodbridge Township.
How many offices does Echo Therapeutics have?
Echo Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies